Santiago
Moreno Guillén
Catedrático/a de Universidad
Instituto de Investigación Sanitaria Gregorio Marañón
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria Gregorio Marañón (21)
2023
-
A Risk Assessment Tool for Predicting Fragility Fractures in People with HIV: Derivation and Internal Validation of the FRESIA Model
Journal of Bone and Mineral Research, Vol. 38, Núm. 10, pp. 1443-1452
-
Contribution of Low CD4 Cell Counts and High Human Immunodeficiency Virus (HIV) Viral Load to the Efficacy of Preferred First-Line Antiretroviral Regimens for Treating HIV Infection: A Systematic Review and Meta-Analysis
Clinical Infectious Diseases, Vol. 76, Núm. 11, pp. 2027-2037
-
IRF5-TNOP3 polymorphisms are associated with elite control of HIV infection: A retrospective study
Journal of medical virology, Vol. 95, Núm. 6, pp. e28841
-
Mortality due to non-AIDS-defining cancers among people living with HIV in Spain over 18 years of follow-up
Journal of Cancer Research and Clinical Oncology, Vol. 149, Núm. 20, pp. 18161-18171
-
Tenofovir Disoproxil Fumarate/Emtricitabine and Baricitinib for Patients at High Risk of Severe Coronavirus Disease 2019: The PANCOVID Randomized Clinical Trial
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 76, Núm. 3, pp. e116-e125
-
Unplanned pregnancies and social and partner support during pregnancy in Spanish women living with HIV
HIV Medicine, Vol. 24, Núm. 6, pp. 727-737
2021
-
COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study
HIV Medicine, Vol. 22, Núm. 9, pp. 867-876
-
Invasive aspergillosis in solid organ transplantation: Diagnostic challenges and differences in outcome in a Spanish national cohort (Diaspersot study)
Mycoses, Vol. 64, Núm. 11, pp. 1334-1345
-
Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)
Clinical Microbiology and Infection, Vol. 27, Núm. 2, pp. 244-252
2020
-
Frailty, markers of immune activation and oxidative stress in HIV infected elderly
PLoS ONE, Vol. 15, Núm. 3
-
Gender-based vulnerability in women who inject drugs in a harm reduction setting
PLoS ONE, Vol. 15, Núm. 3
-
Virological outcome among HIV infected patients transferred from pediatric care to adult units in Madrid, Spain (1997–2017)
Scientific Reports, Vol. 10, Núm. 1
2019
-
Reasons for noncompliance with the national guidelines for initial antiretroviral therapy of HIV-infected patients in Spain, 2010–2015
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 37, Núm. 9, pp. 580-587
2016
-
Human immunodeficiency virus as a chronic disease: Evaluation and management of nonacquired immune deficiency syndrome-defining conditions
Open Forum Infectious Diseases, Vol. 3, Núm. 2
-
Human immunodeficiency virus/hepatitis C virus coinfection in Spain: Prevalence and patient characteristics
Open Forum Infectious Diseases, Vol. 3, Núm. 2
2015
-
Antiretroviral drugs do not interfere with bryostatin-mediated HIV-1 latency reversal
Antiviral Research, Vol. 123, pp. 163-171
-
Bryostatin activates HIV-1 latent expression in human astrocytes through a PKC and NF-κB-dependent mechanism
Scientific Reports, Vol. 5
-
Comparison of the prognostic value of liver biopsy and FIB-4 index in patients coinfected with HIV and hepatitis C virus
Clinical Infectious Diseases, Vol. 60, Núm. 6, pp. 950-958
-
Eficacia de dolutegravir en pacientes experimentados: estudios SAILING y VIKING
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 33, Núm. S1, pp. 26-30
-
Synergistic Activation of Latent HIV-1 Expression by Novel Histone Deacetylase Inhibitors and Bryostatin-1
Scientific Reports, Vol. 5